JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making

JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making is organized by Clinical Care Options (CCO), LLC.,Released: January 10, 2023,Expiration: January 09, 2024,Goal:,The goal of this educational program is to improve knowledge and competence among learners regarding the appropriate use of JAK inhibitors in rheumatoid arthritis to help patients attain low disease activity/remission and improved quality of life.,Learning Objectives:,• Review recent efficacy and safety data for JAK inhibitor therapy in RA,• Assess the benefits and risks of JAK inhibitor therapy for patients with RA based on patient comorbidities and risk factors,• Incorporate practical management and risk mitigation strategies into comprehensive care plans for patients with RA receiving JAK inhibitor therapy,Additional details will be posted as soon as information is available.